Allogeneic stem cell transplantation with dose-reduced conditioning in relapsed follicular and mantle cell lymphoma - A prospective phase II trial of the German low grade lymphoma study group (GLSG)

MH Dreyling; DW Beelen; M Schleuning; AD Ho; M Gramatzki; B Glas; M Pfreundschuh; Martin Wilhelm; N Schmitz; HJ Kolb; M Unterhalt; W Hiddemann

Allogeneic stem cell transplantation with dose-reduced conditioning in relapsed follicular and mantle cell lymphoma - A prospective phase II trial of the German low grade lymphoma study group (GLSG)

MH Dreyling, DW Beelen, M Schleuning, AD Ho, M Gramatzki, B Glas, M Pfreundschuh, Martin Wilhelm, N Schmitz, HJ Kolb, M Unterhalt, W Hiddemann

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	899A-899A
Journal	BLOOD
Volume	110
Issue number	11
Publication status	Published - 2007
Event	49th Annual Meeting of the American-Society-of-Hematology - Atlanta, GA Duration: 8 Dec 2007 → 11 Dec 2007

Cite this

Dreyling, MH., Beelen, DW., Schleuning, M., Ho, AD., Gramatzki, M., Glas, B., Pfreundschuh, M., Wilhelm, M., Schmitz, N., Kolb, HJ., Unterhalt, M., & Hiddemann, W. (2007). Allogeneic stem cell transplantation with dose-reduced conditioning in relapsed follicular and mantle cell lymphoma - A prospective phase II trial of the German low grade lymphoma study group (GLSG). BLOOD , 110(11), 899A-899A.

Dreyling, MH ; Beelen, DW ; Schleuning, M et al. / Allogeneic stem cell transplantation with dose-reduced conditioning in relapsed follicular and mantle cell lymphoma - A prospective phase II trial of the German low grade lymphoma study group (GLSG). In: BLOOD 2007 ; Vol. 110, No. 11. pp. 899A-899A.

@article{b13aeb437037442cae402a6b0fa772ca,

title = "Allogeneic stem cell transplantation with dose-reduced conditioning in relapsed follicular and mantle cell lymphoma - A prospective phase II trial of the German low grade lymphoma study group (GLSG)",

author = "MH Dreyling and DW Beelen and M Schleuning and AD Ho and M Gramatzki and B Glas and M Pfreundschuh and Martin Wilhelm and N Schmitz and HJ Kolb and M Unterhalt and W Hiddemann",

year = "2007",

language = "English",

volume = "110",

pages = "899A--899A",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "11",

note = "49th Annual Meeting of the American-Society-of-Hematology ; Conference date: 08-12-2007 Through 11-12-2007",

}

Dreyling, MH, Beelen, DW, Schleuning, M, Ho, AD, Gramatzki, M, Glas, B, Pfreundschuh, M, Wilhelm, M, Schmitz, N, Kolb, HJ, Unterhalt, M & Hiddemann, W 2007, 'Allogeneic stem cell transplantation with dose-reduced conditioning in relapsed follicular and mantle cell lymphoma - A prospective phase II trial of the German low grade lymphoma study group (GLSG)', BLOOD , vol. 110, no. 11, pp. 899A-899A.

Allogeneic stem cell transplantation with dose-reduced conditioning in relapsed follicular and mantle cell lymphoma - A prospective phase II trial of the German low grade lymphoma study group (GLSG). / Dreyling, MH; Beelen, DW; Schleuning, M et al.
In: BLOOD , Vol. 110, No. 11, 2007, p. 899A-899A.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Allogeneic stem cell transplantation with dose-reduced conditioning in relapsed follicular and mantle cell lymphoma - A prospective phase II trial of the German low grade lymphoma study group (GLSG)

AU - Dreyling, MH

AU - Beelen, DW

AU - Schleuning, M

AU - Ho, AD

AU - Gramatzki, M

AU - Glas, B

AU - Pfreundschuh, M

AU - Wilhelm, Martin

AU - Schmitz, N

AU - Kolb, HJ

AU - Unterhalt, M

AU - Hiddemann, W

PY - 2007

Y1 - 2007

M3 - Abstract (Journal)

SN - 0006-4971

VL - 110

SP - 899A-899A

JO - BLOOD

JF - BLOOD

IS - 11

T2 - 49th Annual Meeting of the American-Society-of-Hematology

Y2 - 8 December 2007 through 11 December 2007

ER -

Dreyling MH, Beelen DW, Schleuning M, Ho AD, Gramatzki M, Glas B et al. Allogeneic stem cell transplantation with dose-reduced conditioning in relapsed follicular and mantle cell lymphoma - A prospective phase II trial of the German low grade lymphoma study group (GLSG). BLOOD . 2007;110(11):899A-899A.